Angela Alexander-Bryant

Angela Alexander-Bryant is an Associate Professor at Clemson University within the College of Engineering, Computing and Applied Sciences. Her research focuses on Drug and Gene Delivery, Biomaterial Design, and Targeted Therapy and Controlled Release, with a particular emphasis on treating heterogeneous and drug-resistant cancers.

• Education: Ph.D. in Bioengineering from Clemson University (2015).

Research Interests center on developing advanced delivery systems for cancer therapy. Key areas include siRNA delivery, self-assembling peptides, and ligand-targeted nanoparticles, aiming to enhance therapeutic efficacy through combination gene-drug approaches and controlled release mechanisms.

Publication Trends show a focus on nanocarriers for glioblastoma, ovarian cancer, and malignant melanoma, with recent work addressing immune resistance in glioblastoma and machine learning analysis of cellular morphology.

Laboratory: Lead the Nanobiotechnology Lab, pioneering peptide-based delivery platforms for gene editing and chemotherapeutics.